Minimally Invasive Thoracic Surgery Market Report 2026

The minimally invasive thoracic surgery market size has grown strongly in recent years. It will grow from $4.38 billion in 2025 to $4.74 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing incidence of thoracic disorders, expansion of specialized surgical centers, improvements in minimally invasive surgical instruments, rising surgeon training in thoracoscopic techniques, growing patient preference for minimally invasive procedures.

The minimally invasive thoracic surgery market size is expected to see strong growth in the next few years. It will grow to $6.46 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of next-generation robotic platforms, rising integration of AI-guided surgical planning, expansion of outpatient thoracic surgery programs, growing demand for high-definition imaging systems, increasing focus on outcome-based surgical care. Major trends in the forecast period include increasing adoption of robotic-assisted thoracic procedures, rising use of advanced visualization systems, growing preference for video-assisted techniques, expansion of precision energy devices, enhanced focus on reduced postoperative recovery time.

The increasing incidence of lung diseases is expected to drive the growth of the minimally invasive thoracic surgery market in the coming years. Lung diseases are medical conditions that impair lung function and breathing, including asthma, COPD, pneumonia, and lung cancer. The rise in lung disease is largely attributed to tobacco smoking, as the harmful chemicals in tobacco damage lung cell DNA over time, increasing the risk of uncontrolled cell growth and tumor development. Minimally invasive thoracic treatments assist patients by targeting and removing or destroying tumors through small incisions or imaging-guided probes, which shortens recovery time, minimizes damage to healthy lung tissue, reduces complication risks, and allows patients to resume normal activities sooner. For example, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the United States recorded 218,893 new lung cancer cases in 2022, and lung cancer caused 131,584 deaths in 2023. Consequently, the rising prevalence of lung diseases is contributing to the expansion of the minimally invasive thoracic surgery market.

Leading companies in the minimally invasive thoracic surgery market are focusing on developing advanced technologies, such as robotic-assisted surgery platforms, to improve surgical precision and overall clinical outcomes. A robotic-assisted surgery platform allows surgeons to control robotic arms to perform minimally invasive procedures with high accuracy, enhancing dexterity, visualization, and precision compared to traditional surgery. For instance, in June 2024, Monmouth Medical Centre (MMC), a US-based medical institution, introduced the Ion Robotic platform, the Aliya PEF system, and intraoperative AI-driven CT imaging. These technologies offer enhanced surgical precision, improved patient outcomes, and real-time imaging to support better decision-making. Together, they enable minimally invasive, precise lung cancer diagnosis and treatment with faster recovery, superior outcomes, real-time navigation, non-thermal tumor ablation, and reduced radiation exposure, facilitating early detection and effective care.

In August 2024, KARL STORZ Endoscopy America Inc., a US-based provider of endoscopic equipment, acquired Asensus Surgical Inc. for $0.35 per share in cash. Through this acquisition, KARL STORZ aims to strengthen its digital and robotic-assisted minimally invasive thoracic surgery capabilities by integrating advanced performance-guided surgery platforms. Asensus Surgical Inc. is a US-based medical device company that provides a robotic-assisted platform specifically designed for minimally invasive thoracic procedures.

Major companies operating in the minimally invasive thoracic surgery market are Johnson And Johnson Services Inc., Medtronic Plc, Koninklijke Philips N.V., Stryker Corporation, GE Healthcare Inc., Olympus Corporation, Intuitive Surgical Operations Inc., Smith & Nephew plc, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Group Incorporated, CONMED Corporation, Applied Medical Resources Corporation, KLS Martin Group, Aesculap Inc., Medela Inc., Richard Wolf GmbH, B. Braun Melsungen AG, Ackermann Instrumente GmbH, Cmr Surgical, Genesee Biomedical Inc.

North America was the largest region in the minimally invasive thoracic surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive thoracic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the minimally invasive thoracic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the minimally invasive thoracic surgery market by increasing costs of imported robotic systems, endoscopic instruments, energy devices, visualization equipment, and disposable surgical components. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported advanced surgical technologies, while Asia-Pacific faces cost pressure on equipment procurement and upgrades. These tariffs are increasing capital investment requirements and slowing technology adoption. However, they are also encouraging regional manufacturing, local assembly partnerships, and innovation in cost-optimized minimally invasive surgical solutions.

The minimally invasive thoracic surgery market research report is one of a series of new reports that provides minimally invasive thoracic surgery market statistics, including minimally invasive thoracic surgery industry global market size, regional shares, competitors with a minimally invasive thoracic surgery market share, detailed minimally invasive thoracic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive thoracic surgery industry. This minimally invasive thoracic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Minimally invasive thoracic surgery (MITS) is a technique that carries out chest procedures through small incisions using specialized instruments, aiming to minimize bodily trauma and postoperative discomfort. This approach reduces hospital stays, accelerates recovery, and provides greater precision and visibility compared to traditional open surgery, ultimately enhancing surgical outcomes and reducing the risk of complications.

The primary types of minimally invasive thoracic surgery include lobectomy, wedge resection, pneumonectomy, and others. A lobectomy is a surgical procedure that removes an entire lobe of an organ, most commonly the lung, to treat disease or damage. These procedures involve various products, including energy devices, instruments, staplers and disposables, and visualization systems, and utilize multiple procedural approaches such as video-assisted thoracoscopic surgery (VATS), robotic-assisted thoracic surgery, endoscopic thoracic surgery, and others. They are applied in a range of surgical areas, including lung cancer, esophageal surgery, and mediastinal surgery, and are used by hospitals, specialty clinics, ambulatory surgical centers, and other healthcare facilities.

The minimally invasive thoracic surgery (MITS) market consists of revenues earned by entities by providing services such as diagnostic endoscopy, preoperative imaging, intraoperative navigation support, postoperative care coordination, and tele-consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive thoracic surgery market also includes sales of energy-based dissection devices, robotic surgical arms, single-use staplers, and ultrasound-guided instrument accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.